90 Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness

Author： Xing Minzhi   Kokabi Nima   Camacho Juan C   Kooby David A   El-Rayes Bassel F   Kim Hyun S  

Publisher： Future Medicine

ISSN： 2042-6305

Source： Journal of Comparative Effectiveness Research, Vol.2, Iss.4, 2013-07, pp. : 435-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 627-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to: “Sorafenib or 90Y loaded resin microsphere radioembolization for locally‐advanced hepatocellular carcinoma, what should we trust?”

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1780-1781

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sorafenib‐ or 90Y‐loaded resin microsphere radioembolization for locally advanced hepatocellular carcinoma, what should we trust?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1779-1780

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: The Emerging Role for Radioembolization Using Yttrium-90

By  

Oncology, Vol. 84, Iss. 5, 2013-04 ,pp. : 311-318

Karger

Access to resources Recommend Favorite

Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 1036-1047

John Wiley & Sons Inc

Access to resources Recommend Favorite